NAPROXEN TABLETS

The Defense Logistics Agency awarded a delivery order, SPE2DP26F7588, to DMS Pharmaceutical Group Inc. (CAGE 1UNB0) for the procurement of 8 bottles of NAPROXEN TABLETS (NSN 6505012002474) at a unit price of $3.69, resulting in a total contract value of $29.52. This order was issued under the basic contract SPE2DX25D9900 and is classified as a delivery/call purchase with no option quantities or variability in quantity, as the variance is strictly fixed at plus or minus 0.00%. Delivery is required FOB destination to Fort Stewart, GA, with a specified delivery date of July 29, 2026, and inspection and acceptance to occur at the destination. The contractor is required to ship the product via the fastest traceable means, explicitly prohibiting parcel post, and all packaging and documentation must be marked with the base contract number SPE2DX-25-D-9900, the delivery order number SPE2DP-26-F-7588, and the Transportation Control Number W33RBS61940100. No specific packaging, preservation, or bar-coding standards are detailed in the order, though general DoD marking conventions are implied. The contractor is certified as a small business, small disadvantaged business, and women-owned small business, triggering obligations under FAR Part 19 to maintain eligibility and potentially submit subcontracting reports. Payment is to be processed through the Defense Finance and Accounting Service in Columbus, Ohio, using the accounting code BX: 97X4930 5CBX 001 2620 S33189, though the invoicing method is unspecified. The contracting officer is Lisa Quinn, reachable via email at LISA.QUINN@DLA.MIL, with no named contracting officer’s representative. The award was issued on July 14, 2026, with no amendments or modifications referenced. No special requirements, evaluation factors, or formal contract clauses are included in the documentation, suggesting reliance on the underlying basic contract for terms and conditions, and no attachments or MIL-STD references are cited for packaging or labeling.